GLP-1 Microdosing Strategy Combines Low-Dose Peptides with Behavior Change for Weight Loss
Noom CEO explains how microdosing GLP-1 with behavior modification creates sustainable weight loss beyond traditional peptide approaches.
20 articles
Noom CEO explains how microdosing GLP-1 with behavior modification creates sustainable weight loss beyond traditional peptide approaches.
Dr. Uri Alon uses a simple village model to reframe aging as a balance between damage accumulation and cleanup capacity.
Researchers explore how eliminating senescent cells could revolutionize longevity medicine and healthy aging.
Recent longevity podcasts explore AI-powered supplement stacks, regenerative medicine breakthroughs, and critical takes on peptide culture.
Modern life has turned us into zoo animals. Learn how strategic discomfort can reverse chronic disease and restore vitality.
Dr. Tim Spector shares breakthrough findings from the largest microbiome study and why most probiotics are scientifically obsolete.
New mitochondrial testing technology helps optimize your health interventions based on cellular function data.
Direct-to-consumer biological age tests promise health insights but may deliver misleading results that confuse more than clarify.
Biotech company reports positive preliminary results from clinical trial testing cellular rejuvenation therapy targeting aging cells.
Two leading entrepreneurs discuss breakthrough health technologies and precision medicine tools that can extend lifespan today.
Expert reveals how women should train differently from men, covering resistance training, cardio, and nutrition optimization.
Dr. Michael Snyder reveals how continuous glucose monitors and smartwatches can detect illness onset and optimize metabolic health.
Jim LaValle shares decades of experience with innovative peptides, metabolic testing, and personalized health optimization strategies.
Scientists discover two polyunsaturated fatty acids that may help eliminate aging cells, offering potential longevity benefits.
A leading aging researcher audits NMN, urolithin A, spermidine, and more — revealing what actually works and what falls short.
A Stanford drug development expert breaks down why most peptide compounds circulating online lack the safety and efficacy data required for human use.
Dr. Harry Adelson and Dr. Amy Killen reveal how U.S. stem cell treatments now rival international clinics for regenerative medicine.
Dr. Jeffrey Gladden explores how AI is revolutionizing personalized longevity protocols and supplement stacks for optimal healthspan.
Board-certified reproductive endocrinologist reveals how fertility testing provides powerful insights into overall health and aging.
Peter Attia breaks down the real impact of Ozempic and Wegovy on muscle, bone, and physical function — and how to protect both.